Safura Abdool Karim

Public Health Lawyer | Researcher

COVID-19: The Challenge of Global Vaccine Inequity


Journal article


S. Karim, Q. Karim, S. Karim
Social research, 2023

Semantic Scholar DOI
Cite

Cite

APA   Click to copy
Karim, S., Karim, Q., & Karim, S. (2023). COVID-19: The Challenge of Global Vaccine Inequity. Social Research.


Chicago/Turabian   Click to copy
Karim, S., Q. Karim, and S. Karim. “COVID-19: The Challenge of Global Vaccine Inequity.” Social research (2023).


MLA   Click to copy
Karim, S., et al. “COVID-19: The Challenge of Global Vaccine Inequity.” Social Research, 2023.


BibTeX   Click to copy

@article{s2023a,
  title = {COVID-19: The Challenge of Global Vaccine Inequity},
  year = {2023},
  journal = {Social research},
  author = {Karim, S. and Karim, Q. and Karim, S.}
}

Abstract

Abstract:Several safe and effective COVID-19 vaccines were developed, evaluated, and made available in record time during the pandemic. But hopes of equitable access to COVID-19 vaccines were dashed by corporate greed, political expediency, global trade agreements, and intellectual property ownership, delaying or denying access for poor countries. Once vaccines became widely available, their benefits were curtailed by anti-science sentiment and anti-vaccine conspiracy theories. Building trust in science is key to preparing for the next pandemic.


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in